The BioInfect AMR Conference convened more than 170 delegates at the Apiary in Alderley Park on 5th February, creating a focused forum for discussion on the escalating threat of antimicrobial resistance and the urgent need for coordinated action.
The agenda presented talks and discussions across a range of topics, including the state of the drug discovery and development pipeline; how to increase engagement and communication around AMR; tracking resistance in a changing world; a funding and investment update from the Biologics Regional Innovation Technology System (BRITE) partnership; and a discussion about the role vaccines play in combating infections.
Read the full event summary here
BioInfect 2026 is supported by Bruntwood SciTech, Evotec, iiCON, Appleyard Lees and the Liverpool School of Tropical Medicine Enterprise & Innovation.
Agenda highlights:
Keynote Speakers
Mark Woolhouse, Professor of Infectious Disease Epidemiology, University of Edinburgh
Nick Feasey, Sir James Black Professor of Infection Medicine, University of St Andrews, Professor of Microbiology Liverpool School of Tropical medicine and Malawi Liverpool Wellcome Programme
Sam Rhoden, Business Development Manager, LifeArc
Daire Cantillon, Lecture in Infection Biology and Therapeutics, Liverpool School of Tropical Medicine
State of the Possible Panel
Chair: Alastair Parkes, VP Medicinal Chemistry, Evotec
Speakers
Becky Jones-Phillips, Head of Innovation and Enterprise, Liverpool School of Tropical Medicine
Michael Bromley, Director, Manchester Fungal infection Group, University of Manchester
Marian Rehak, Technical Director, Mast Group
David Chapman, Head of Biology, Centauri Therapeutics
Mick Cooper, Life Sciences Specialist, Office of Life Sciences
What's in the Pipeline
Chair: James Myatt, Partner, Appleyard Lees
Speakers
Janet Hemingway, Founding Director, iiCON
Lydia Tabernero, Professor of Structural Biology and Drug Discovery, Tabrix
Tom Swift, Founder, Molecular Titans
Jonathan Jones, Manager – Microbial Upstream, CPI
Increasing Engagement and Communication Panel
Chair: Stephen Adams, Associate Director, Optimum Strategic Communications
Speakers
Charles McLoughlin, Innovation Strengthening Programme Manager, LSTM
Connie Takawira, AMR Senior Partnership Manager, MDC
John Dyer, Project Based Learning and Innovation Lead at Liverpool Life Sciences UTC.
Ava Knowles, Student, Liverpool Life Sciences UTC
Ed Siegwart, Director of Microbiology, Oppilotech
Tracking Resistance in a Changing World
Speakers
Diana Mogrovejo, Scientific Project Manager, Dr Brill Institutes
Fabrice Graf, Lecturer in Antimicrobial Resistance, Liverpool School of Tropical Medicine
Ines Moura, Lecturer in Medical Microbiology, University of Leeds
Funding and Investment – BRITE
Daire Cantillon, Lecture in Infection Biology and Therapeutics, Liverpool School of Tropical Medicine
Vaccines Discussion
Speakers
Neil Murray, CEO, ReNewVax
Jonathan Heddle, Founder/CSO, nCage Therapeutics
Asel Sartbaeva, CEO & Co-Founder, EnsiliTech
Simon Oakley, Senior Medical Science Liaison, Valneva
